ArticleFrontiers in medicine2025
Empowering biomedical learners to navigate FDA regulatory processes and entrepreneurship with a novel interdisciplinary training approach.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For rising professionals to meet the needs of contemporary healthcare and biomedical innovation, educators must develop new teaching and learning approaches. Specifically, biomedical innovations are significantly influenced by the FDA's regulatory framework, requiring professionals to be equipped with regulatory science knowledge, entrepreneurial skills, and interdisciplinary training. However, biomedical education often fails to integrate these skills in an environment that mimics the interdisciplinary setting required for translational science, leaving learners unprepared for unique challenges in practice. This study details an FDA Regulation and Entrepreneurship curriculum at Case Western Reserve University and its affiliated community, leveraging a novel approach for biomedical education. Focused on preparing biomedical professionals to navigate FDA regulatory processes and innovative entrepreneurship endeavors, the curriculum is built upon five core principles: integrating multiple disciplines, ensuring real world applicability, developing a systems thinking approach, incorporating ethical considerations, and fostering a collaborative and experiential learning environment. These principles are supported by a flexible course format, targeted learning objectives, team-based learning sessions, experiential learning opportunities, a diverse participant population, and an interdisciplinary team of faculty and experts. High participant engagement and broad representation across fields over the curriculum's three-year lifespan to date affirm its relevance and value with participants representing the fields of basic science, medicine, law, business, and engineering. The flexible course format, team-based learning, and experiential learning proved instrumental in enhancing engagement, reinforcing practical learning outcomes, and supporting personalized learning goals. The flexible course format further aligns with professional needs of participants, providing a model for other institutions navigating similar challenges in biomedical education. In conclusion, participant feedback demonstrated the value of the interdisciplinary and transdisciplinary training approach in promoting knowledge retention and skill development in complex medical, business management and legal contexts. Moving forward, targeted outreach and flexible engagement options will be necessary to expand the curricular reach and diverse participant population. The success of the curriculum suggests promising implications for similar approaches aimed at empowering biomedical professionals with essential regulatory, entrepreneurial and interdisciplinary competencies, ultimately advancing translational science and improving healthcare outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.